Anocca
Anocca AB provides services like Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology.
Södertälje, Swedenwww.anocca.com ↗
Total raised
€104M
€104,476,304
Funding rounds
3
Investors
11
distinct backers
Active since
2021-08
latest 2025-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood40
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
Exit likelihood21
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €100M+ raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-20 | Other | €39M | AMF,Existing Shareholders,Mellby Gård,new investors,Ramsbury Invest | View deal → |
| 2022-12-21 | Debt | €25M | European Investment Bank | View deal → |
| 2021-08-03 | Series B | €40M | Harald Mix,Mellby Gård,Michano,Nidoco,Ramsbury Invest,Robert Andreen+1 more | View deal → |
Investors
11Related news
- Anocca Secures EUR 25M from the European Investment Bankfinsmes.com · 2022-12
- Sweden’s Anocca raises €40M to develop novel therapeutics for cancer, infectious disease, autoimmunitysiliconcanals.com · 2021-08
- finsmes.com